Dermatologicals in Japan
Dermatologicals is set to see similar slow current value growth in 2022 as witnessed in 2021, but performances are expected to vary depending on the category. For example, haemorrhoid treatments, hair loss treatments and cold sore treatments are expected to show current value growth, whilst antipruritics is set to decline. Haemorrhoid treatments is expected to see value growth, mainly due to price rises, but also due to some consumers suffering from symptoms due to lifestyles triggered by COVID-...
Euromonitor International's Dermatologicals in Japan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.
Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook